Albany Molecular CEO got 32% pay raise in '05.(Business)

ALBANY - Drug discovery company Albany Molecular Research Inc. gave its chairman and chief executive, Thomas E. D'Ambra, a 32 percent raise in 2005.

But because his his base pay is dwarfed by Allegra patent royalties, his total 2005 compensation grew by just 2.2 percent.

In all, D'Ambra made $5.2 million in 2005, up from $5 …